Literature DB >> 22861368

Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination.

S K Sharma1, M E Pichichero.   

Abstract

Understanding the immune responses that explain why infants require multiple doses of pertussis vaccine to achieve protection against infection is a high priority. The objective of this study was to compare the function and phenotypes of antigen-specific CD4(+) T cells in adults (n=12), compared to infants (n=20), following vaccination with acellular pertussis (DTaP) vaccine. Peripheral blood mononuclear cells (PBMCs) were stimulated with pertussis toxoid (PT), pertactin (PRN) and filamentous haemagglutinin (FHA). Multi-parameter flow cytometry was used to delineate CD4(+) T cell populations and phenotypes producing interferon (IFN)-γ, interleukin (IL)-2, tumour necrosis factor (TNF)-α and IL-4. Based on surface CD69 expression, infants demonstrated activation of vaccine antigen-specific CD4(+) T cells similar to adults. However, among infants, Boolean combinations of gates suggested that type 1 (Th-1) CD4(+) T cell responses were confined largely to TNF-α(+) IL-2(+) IFN-γ(-) or TNF-α(+) IL-2(-) IFN-γ(-) . A significantly lower percentage of polyfunctional T helper type 1 (Th1) responses (TNF-α(+) IFN-γ(+) IL-2(+) ) and type 2 (Th2) responses (IL-4) were present in the infants compared to adults. Moreover, a significantly higher percentage of infants' functional CD4(+) T cells were restricted to CD45RA(-) CCR7(+) CD27(+) phenotype, consistent with early-stage differentiated pertussis-specific memory CD4(+) T cells. We show for the first time that DTaP vaccination-induced CD4(+) T cells in infants are functionally and phenotypically dissimilar from those of adults.
© 2012 The Authors. Clinical and Experimental Immunology © 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22861368      PMCID: PMC3445005          DOI: 10.1111/j.1365-2249.2012.04613.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  52 in total

1.  Panel backs wider pertussis vaccination to curb outbreaks, prevent deaths.

Authors:  Bridget M Kuehn
Journal:  JAMA       Date:  2010-12-22       Impact factor: 56.272

2.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-01-14       Impact factor: 17.586

3.  Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age.

Authors:  Nicholas Wood; Peter McIntyre; Helen Marshall; Don Roberton
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129

Review 4.  Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.

Authors:  Courtney A Gidengil; Thomas J Sandora; Grace M Lee
Journal:  Expert Rev Vaccines       Date:  2008-07       Impact factor: 5.217

5.  Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries.

Authors:  Mirjam Kretzschmar; Peter F M Teunis; Richard G Pebody
Journal:  PLoS Med       Date:  2010-06-22       Impact factor: 11.069

6.  T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.

Authors:  Pascal Feunou Feunou; Julie Bertout; Camille Locht
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

7.  Th2-polarisation of cellular immune memory to neonatal pertussis vaccination.

Authors:  Olivia J White; Julie Rowe; Peter Richmond; Helen Marshall; Peter McIntyre; Nicholas Wood; Patrick G Holt
Journal:  Vaccine       Date:  2010-01-20       Impact factor: 3.641

Review 8.  Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells.

Authors:  Habib Zaghouani; Christine M Hoeman; Becky Adkins
Journal:  Trends Immunol       Date:  2009-10-19       Impact factor: 16.687

9.  Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune response.

Authors:  Nikolaus Rieber; Anna Graf; Dominik Hartl; Simon Urschel; Bernd H Belohradsky; Johannes Liese
Journal:  PLoS One       Date:  2011-03-08       Impact factor: 3.240

10.  Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: a randomized controlled trial in Papua New Guinea.

Authors:  Anita H J van den Biggelaar; Peter C Richmond; William S Pomat; Suparat Phuanukoonnon; Marie A Nadal-Sims; Catherine J Devitt; Peter M Siba; Deborah Lehmann; Patrick G Holt
Journal:  Vaccine       Date:  2009-01-14       Impact factor: 3.641

View more
  13 in total

Review 1.  Cellular immune response in young children accounts for recurrent acute otitis media.

Authors:  Sharad K Sharma; Michael E Pichichero
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

2.  Identification of pertussis-specific effector memory T cells in preschool children.

Authors:  Lia de Rond; Rose-Minke Schure; Kemal Öztürk; Guy Berbers; Elisabeth Sanders; Inonge van Twillert; Maria Carollo; Françoise Mascart; Clara M Ausiello; Cecile A C M van Els; Kaat Smits; Anne-Marie Buisman
Journal:  Clin Vaccine Immunol       Date:  2015-03-18

Review 3.  What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

Authors:  Nicolas Burdin; Lori Kestenbaum Handy; Stanley A Plotkin
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-12-01       Impact factor: 10.005

4.  Differential impact of respiratory syncytial virus and parainfluenza virus on the frequency of acute otitis media is explained by lower adaptive and innate immune responses in otitis-prone children.

Authors:  David Verhoeven; Qingfu Xu; Michael E Pichichero
Journal:  Clin Infect Dis       Date:  2014-04-29       Impact factor: 9.079

5.  Poor memory B cell generation contributes to non-protective responses to DTaP vaccine antigens in otitis-prone children.

Authors:  S Basha; M E Pichichero
Journal:  Clin Exp Immunol       Date:  2015-09-30       Impact factor: 4.330

Review 6.  Pertussis re-emergence in the post-vaccination era.

Authors:  Elena Chiappini; Alessia Stival; Luisa Galli; Maurizio de Martino
Journal:  BMC Infect Dis       Date:  2013-03-26       Impact factor: 3.090

Review 7.  Immune responses in neonates.

Authors:  Saleem Basha; Naveen Surendran; Michael Pichichero
Journal:  Expert Rev Clin Immunol       Date:  2014-08-04       Impact factor: 4.473

8.  Nonprotective responses to pediatric vaccines occur in children who are otitis prone.

Authors:  Michael E Pichichero; Janet R Casey; Anthony Almudevar
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

9.  CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens.

Authors:  Sharad K Sharma; David Roumanes; Anthony Almudevar; Tim R Mosmann; Michael E Pichichero
Journal:  Vaccine       Date:  2013-04-28       Impact factor: 3.641

Review 10.  Challenges in vaccination of neonates, infants and young children.

Authors:  Michael E Pichichero
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.